HS-1002

N/A

Report date: 2024/07/05 17:38:09
NME

Base Information

Drug NameHS-1002
Drug Alias NameHS1002HS-1002
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGonadotropin-releasing hormone modulatorsHuman telomerase (hTERT)-directed cytolytic effects
TargetsGonadotropin-releasing hormoneTelomerase reverse transcriptase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSungkyunkwan University
China Registration ClassN/A

Develop Information

Active CompaniesSungkyunkwan University
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A